laitimes

Stable vital signs! Xiao Jingyi's latest treatment progress is coming

author:Beijing News Network

On the evening of December 22, the emergency department of the Capital Pediatric Research Institute came to a special child, he was xiao Jingyi, who suffered from spinal muscular atrophy (SMA), which touched the hearts of netizens across the country, from Changsha to Beijing, Xiao Jingyi had a heart rate of 190 beats / min twice along the way, which made his parents and accompanying emergency personnel nervous. After arriving at Beijing West Railway Station, the ambulance sped all the way, and with the help of Beijing traffic police, Beijing volunteer first aid volunteers and many other personnel, it took only 16 minutes to successfully reach the Capital Institute of Pediatrics.

On the afternoon of December 23, Xiao Jingyi, who had undergone various examinations, was admitted to the respiratory medicine ward. Cao Ling, director of the Department of Respiratory Medicine of Shou'er Institute, said that at present, Xiao Jingyi's vital signs are relatively stable, and there is some significant increase in heart rate, and follow-up needs to further evaluate the situation of nerves, cardiovascular, digestion, nutrition and other aspects, and treat them through multidisciplinary management methods.

Stable vital signs! Xiao Jingyi's latest treatment progress is coming

Xiao Jingyi has drug-resistant bacterial pneumonia, spinal muscular atrophy leads to respiratory muscle weakness, especially during the infection period, he can not effectively maintain blood oxygen saturation, and needs a ventilator to assist breathing. At the same time, Xiao Jingyi can not discharge the secretions in the airway, so after each use of atomization pump, vibrating sputum discharge, position drainage treatment, it is necessary to use a sputum coughing machine and suction sputum through the mouth and nose. Respiratory failure can be alleviated through careful respiratory management plus antimicrobial treatment.

Spinal muscular atrophy (SMA) is a neuromuscular disease caused by a defect in the function of motor neuron survival gene protein caused by mutations in the survival motor neuron gene 1 (SMN1), which is a hereditary neuromuscular disease that is more common in childhood, with an incidence of one in 10,000 in newborns, caused by damage to motor nerve cells in the anterior horn of the spinal cord. It is characterized by progressive muscle weakness and muscle atrophy dominated by the lower extremities. Xiao Jingyi belongs to the SMA-I. type, most of these children have the onset within 6 months, the disease progresses rapidly, and it is impossible to achieve large movements such as sitting alone, turning over, climbing, etc., and will often involve breathing and swallowing as the disease progresses.

(Original title: Tracking | Vital Signs Stable!) Xiao Jingyi's latest treatment progress is coming)

Source: Beijing Daily Client | Reporter Yang Xujun Chu Yingshuo Correspondent Chi Yang

Process Edit: U016

Read on